| __timestamp | Amphastar Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 2917513 |
| Thursday, January 1, 2015 | 46974000 | 7878291 |
| Friday, January 1, 2016 | 47298000 | 8366794 |
| Sunday, January 1, 2017 | 50918000 | 6610381 |
| Monday, January 1, 2018 | 58044000 | 6556000 |
| Tuesday, January 1, 2019 | 63109000 | 6930000 |
| Wednesday, January 1, 2020 | 65157000 | 8758000 |
| Friday, January 1, 2021 | 68920000 | 10806000 |
| Saturday, January 1, 2022 | 66592000 | 9844000 |
| Sunday, January 1, 2023 | 80393000 | 13481000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. Over the past decade, Amphastar Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. Amphastar's SG&A expenses have surged by approximately 99% from 2014 to 2023, reflecting their aggressive expansion and operational scaling. In contrast, Soleno's expenses have increased by about 362% during the same period, indicating a strategic shift towards growth and development.
These trends underscore the dynamic strategies employed by both companies in navigating the pharmaceutical industry.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: argenx SE vs Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amphastar Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.